Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 31
  • 1
  • 2
  • »
ACCC Buzz had an opportunity to speak with Jonathan Govette, co-founder and chief operating officer at Oatmeal Health, to learn more about its virtual clinic and patient engagement services and cancer screenings.
ACCCBuzz spoke with Luis E. Raez, MD, FACP, FCCP, to learn more about the importance of closing the gap in access to biomarker testing and strategies to improve equity and inclusion in precision medicine.
ACCC held a LinkedIn live event on March 13, 2023, with subject matter experts, who shared strategies for tackling lung cancer disparities in the Appalachian Region and beyond.
With the variety of models and titles that have emerged under precision medicine stewardship, learn how one cancer program is breaking down the this complex landscape into streamlined workflows to improve efficiency and better support growing test volumes.
ACCC is recognizing National Colorectal Cancer Awareness Month by highlighting the importance of cancer screenings and early detection.
Approximately 13,000 people in the U.S. are diagnosed with cervical cancer annually, with the highest incidence rates among the Appalachian region. Learn how the ACCC Appalachian Community Cancer Alliance is working to improve cancer care delivery in this region and beyond.
ACCC shares how a precision medicine steward—a dedicated navigator focused specifically on biopsy samples and biomarker testing processes and results—can make a daunting biomarker testing process incredibly efficient for cancer programs and practices everywhere.
Dr. John Strickler from Duke Cancer Institute sat down with ACCCBuzz to talk about molecular profiling and data, including the cancer institute's own journey in oncology precision medicine.
November 13 to 19 is dedicated to National Nurse Practitioner Week, and the Association of Community Cancer Centers (ACCC) is taking this opportunity to recognize its nurse practitioner (NP) members—highlighting the work NPs do to improve access to care, the patient and clinician experience, and patient outcomes.
Introduced in 2021, the Cancer Patient Equity Act seeks to provide coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program, and more.
ACCCBuzz shares highlights from the NCCN Policy Summit: Reducing the Cancer Burden through Prevention and Early Detection, highlighting the real impacts felt by patients and providers in cancer risk identification and reduction.
Care optimization is everything in today’s rapidly changing healthcare landscape. Learn how ACCC's nationwide quality improvement (QI) initiative helped Southern Ohio Medical Center Cancer Center develop and implement plans to support the optimization of care for patients diagnosed with Stages III and IV non-small cell lung cancer (NSCLC).
On September 16, the National Comprehensive Cancer Network convened experts and stakeholders in D.C. for a policy summit spotlighting today’s cancer screening and prevention landscape. Learn what speakers discussed, including what changes need to happen to create an equitable future for all people at risk—or not—for cancer.
Cancer programs and practices can leverage technology to mitigate the impact of social determinants of health (SDOH). Learn about three companies and their technology that is developed to advance equity in cancer care delivery.
Communities around the globe recognize August 1 as World Lung Cancer Day—a day to commemorate, educate, and support individuals and families impacted by lung cancer. Read highlights on a few ACCC initiatives that are helping cancer care teams better support their patients with this disease.
To fill a care gap, The James Cancer Hospital opened a new set of front doors to its facility—The James Cancer Diagnostic Center—to ensure all patients with a concern for cancer could be quickly evaluated, even if they didn’t have a confirmed diagnosis.
Measurable residual disease (MRD) has gained traction as a compelling marker for disease status across various hematologic malignancies, including multiple myeloma. Learn how MRD is uniquely suited to help evaluate the depth of treatment response.
With data already demonstrating the role of MRD for CLL response assessment and prognosis, cancer programs should prepare themselves for implementation of MRD testing for appropriate patients.
Advocating on behalf of their patients and programs, ACCC members from 14 states participated in Virtual Hill Day, speaking with Congress and their staff on key legislation asks regarding access to care, telehealth, prior authorizations, and more.
ACCC has partnered with several of its oncology state societies to establish the Appalachian Community Cancer Alliance—a key effort to address disparities in cancer screening and care delivery in the region.
    Displaying results 1 - 20 of 31
  • 1
  • 2
  • »